Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fusarium messenger RNA (mRNA) represents a class of therapeutic and biotechnological targets within the genus Fusarium, which includes significant plant and human pathogens such as F. graminearum and F. oxysporum [1]. These mRNA molecules are essential for the translation of proteins required for fungal metabolism, cell wall integrity, and virulence [2]. In recent years, Fusarium mRNA has become a primary focus for RNA interference (RNAi) strategies, including Host-Induced Gene Silencing (HIGS) and Spray-Induced Gene Silencing (SIGS) [3]. By delivering double-stranded RNA (dsRNA) or small interfering RNA (siRNA) that is complementary to specific fungal transcripts—such as those encoding CYP51 or chitin synthases—researchers can trigger the degradation of the target mRNA, effectively halting fungal growth [4]. This approach is primarily applied in agriculture to combat crop diseases like Fusarium head blight and Fusarium wilt [5]. However, it is also being investigated for clinical applications in treating invasive fusariosis and fungal keratitis in humans [6]. The specificity of RNAi allows for targeting fungal transcripts without affecting the host's own mRNA, reducing potential toxicity [7]. Challenges remain regarding the delivery and stability of RNA-based agents in complex environments [8]. Sources: [1] https://doi.org/10.1073/pnas.1306601110; [2] https://doi.org/10.3389/fpls.2016.00204; [3] https://doi.org/10.1111/pbi.13569; [4] https://doi.org/10.1371/journal.ppat.1003664; [5] https://doi.org/10.1007/s00299-014-1672-6; [6] https://pubmed.ncbi.nlm.nih.gov/32164156/; [7] https://www.nature.com/articles/s41467-019-13274-y; [8] https://doi.org/10.3389/fpls.2018.01039.
RNA interference (RNAi) leading to sequence-specific degradation of target mRNA and subsequent gene silencing.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fusarium messenger RNA (Fusarium mRNA).